V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
Dodge & Cox Stock Fund Portfolio 13F
Dodge & Cox Stock Fund Holdings Activity
- Portfolio value:
- $88.92B≈ (+$731M≈)
- Previous value:
- $88.19B≈
- # of changes:
- 32
- New positions:
- 2
- Reported for:
- 31 Mar 2023 (Q1)
- Latest filing date:
- 26 May 2023
Dodge & Cox Stock Fund has disclosed a total of 32 changes to the portfolio in the (2023 Q1) SEC report(s): increased the number of shares of 15, bought 2 totally new, decreased the number of shares of 10 and completely sold out 5 position(s).
What stocks did Dodge & Cox Stock Fund buy in 2023 Q1?
During 2023 Q1 Dodge & Cox Stock Fund has bought 17 securities out of which top 5 purchases (by % change to portfolio) were (WFC) Wells Fargo & Company (added shares +3.15%), (SCHW) Charles Schwab Corp (added shares +1.62%), (MET) MetLife Inc (added shares +0.77%), (CHTR) Charter Communications Inc (added shares +5.31%) and (GSK) GlaxoSmithKline PLC ADR (added shares +9.10%).
What did Dodge & Cox Stock Fund invest in during 2023 Q1?
32 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Dominion Energy Inc
|
new
|
+9,771,900
|
9,771,900
|
+0.61%
|
$55.91
|
+24.66%($69.70)
|
0.61%
|
2023 Q1
|
≈ 0.25 years
|
|
|
|
GE HealthCare Technologies Inc
|
new
|
+9,846,866
|
9,846,866
|
+0.91%
|
$82.03
|
-17.15%($67.96)
|
0.91%
|
2023 Q1
|
≈ 0.25 years
|
|
|
|
Medtronic PLC
|
+64.70%
|
+1,977,300
|
5,033,300
|
+0.18%
|
$80.62
|
+5.88%($85.36)
|
0.46%
|
2019 Q3
|
≈ 3.75 years
|
|
|
|
Alphabet Inc, CL-A
|
+41.24%
|
+2,850,100
|
9,761,800
|
+0.33%
|
$103.73
|
+241.03%($353.76)
|
1.14%
|
2019 Q3
|
≈ 3.75 years
|
|
|
|
Amazon.com Inc
|
+20.51%
|
+1,936,700
|
11,378,000
|
+0.22%
|
$103.29
|
+162.42%($271.05)
|
1.32%
|
2022 Q3
|
≈ 0.75 years
|
|
|
|
Haleon plc
|
+19.47%
|
+12,443,236
|
76,361,577
|
+0.11%
|
$8.14
|
+21.31%($9.88)
|
0.70%
|
2022 Q3
|
≈ 0.75 years
|
|
|
|
Bank of America Corp
|
+11.73%
|
+3,033,400
|
28,896,900
|
+0.1%
|
$28.60
|
+117.22%($62.13)
|
0.93%
|
2019 Q3
|
≈ 3.75 years
|
|
|
|
Truist Financial Corp
|
+11.04%
|
+1,414,400
|
14,229,444
|
+0.05%
|
$34.10
|
+52.18%($51.90)
|
0.55%
|
2019 Q3
|
≈ 3.75 years
|
|
|
|
Baker Hughes Co
|
+9.71%
|
+2,015,100
|
22,766,608
|
+0.07%
|
$28.86
|
+109.48%($60.46)
|
0.74%
|
2019 Q3
|
≈ 3.75 years
|
|
|
|
GlaxoSmithKline PLC ADR
|
+9.10%
|
+4,138,800
|
49,599,557
|
+0.17%
|
$35.58
|
+45.66%($51.82)
|
1.98%
|
2019 Q3
|
≈ 3.75 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.